Aruna Biomedical

ArunA Biomedical Announces Induced Pluripotent Stem Cell Advancement using viPS™ Vector Kit

FOR RELEASE MAY 11, 2010 Biosciences Media Contact: ArunA Biomedical, Inc. Tracey Worthington Stice Phone: (706) 542-9191 Email: tworth@arunabiomedical.com ...

ArunA Biomedical announces co-development of fully validated induced pluripotent stem cell kit

Athens, Georgia - - March 31, 2009. ArunA Biomedical, Inc., a leader in human embryonic stem cell derived products, announced today that it has co-developed a validated kit to produce induced pluripot...

ArunA Biomedical Announces Commercial Release of its Human Embryonic Stem Cell Derived Mesenchymal Cells

Athens, Georgia – March 27, 2009 -- ArunA Biomedical, Inc., announced today that it will make its CELL-EZ™ brand hMC™ human mesenchymal progenitor cells commercially available to the...

ArunA Biomedical, Inc. announces alliance with Neuromics for distribution of normal human neural cells.

Athens, Georgia - - March 23, 2009 - - ArunA Biomedical, Inc., announced today an agreement with Neuromics, Inc. of Edina, MN, giving Neuromics the right to non-exclusively market and sell the Ar...

ArunA Biomedical Announces Commercial Release of its Human Embryonic Stem Cell Derived Neural Cells

Athens, Georgia – January 30, 2009 -- ArunA Biomedical, Inc., announced today that it will make its hN2™ cells commercially available to the research community in early 2009. The cel...

iPSc breakthrough at UGA may lead to improved models for regenerative medicine

UGA discovery holds promise for treatment of diabetes, other debilitating diseases May 4, 2010 By J Faith Peppers University of Georgia ATHENS – Two University of Georgia animal science res...

ArunA Biomedical Names Harold Ingalls to its Board of Directors

ArunA Biomedical Names Harold Ingalls to its Board of DirectorsAthens, Georgia – September 9, 2008 -- ArunA Biomedical, Inc., the first company to commercialize human embryonic stem cell d...

ArunA Biomedical announces exclusive worldwide technology license agreement to commercialize human embryonic stem cell derived mesenchymal cells

Athens, Georgia - - August 19, 2008 ArunA Biomedical, Inc., a leader in human embryonic stem cell derived products, announced today that it has entered into an exclusive worldwide technology licensing...

Innovation Conversation (Podcast)

Innovation Conversation (Podcast) Click Here to hear the podcast ClearCast

Stem cell breakthrough: UGA researcher's work could aid national security

Stem cell breakthrough: UGA researcher's work could aid national security Atlanta Journal Constitution, September 23, 2007 Click Here to read the full article.

On The Cutting Edge

On The Cutting Edge Georgia Trend Magazine, June 2007 http://www.georgiatrend.com/cover-story/06_07_stice.shtml

Research rich in potential: firm’s stem cell discovery could mean cures, profits

Research rich in potential: firm’s stem cell discovery could mean cures, profits Athens Banner Herald, February 10, 2007 http://www.onlineathens.com/stories/021107/uganews_2007021110...

Cell discovery at UGA could open path to breakthroughs

Cell discovery at UGA could open path to breakthroughs Atlanta Journal Constitution, January 26, 2007 CLICK HERE to read the full article...

Aruna Biomedical, Inc. announces technology licensing agreement to commercialize the first products derived from human embryonic stem cells

Aruna Biomedical, Inc. announces technology licensing agreement to commercialize the first products derived from human embryonic stem cells, Aruna Biomedical

Aruna Biomedical, Inc. announces technology licensing agreement to commercialize the first products derived from human embryonic stem cells.

Athens, Georgia - - January 25, 2007 - - Aruna Biomedical, Inc., announced today that it has entered into a technology licensing agreement with the University of Georgia Research Foundation that will ...